Pharmanovia A/S: Financial statements 2025
CVR: 32287824
Source: annual report 2025, Danish Business Authority
01/04/2024 – 31/03/2025
Pharmanovia A/S (CVR 32287824) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 6,024,928 and a net result of DKK 3,839,334 compared with EUR 2,246,626 the year before. That is an increase of 28.6% compared with the year before. Equity in the 2025 report amounted to DKK 8,089,944. The solvency ratio was 20.3%. The company had 12 employees in the financial year.
- Gross Profit
- DKK 6,024,928
- Profit/Loss
- DKK 3,839,334
- Equity
- DKK 8,089,944
- Total Assets
- DKK 39,941,064
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 6M | 3.8M | 8.1M | 12 |
| 2024 | - | 4.7M EUR | 2.2M EUR | 4.9M EUR | 12 |
| 2023 | - | 44M | 26.1M | 19.6M | 15 |
| 2022 | - | 3.4M | -21.6M | -6.5M | 18 |
| 2021 | - | 15.2M | -2M | 15.1M | 15 |
Official annual report
How creditworthy is Pharmanovia A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of November 26, 2025, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of Pharmanovia A/S.
As of November 26, 2025, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Pharmanovia A/S.
Pharmanovia A/S has won the tender "Amgros 2026 1.1202.a" issued by Amgros I/S worth 383,606,720 DKK.
Pharmanovia A/S has won the tender "Amgros 2026 1.1203.a" issued by Amgros I/S worth 368,505,024 DKK.
As of September 30, 2025, James Sang Bum Lee has left the board of directors of Pharmanovia A/S.
As of September 30, 2025, Zubair Javeed has left the board of directors of Pharmanovia A/S.
As of September 30, 2025, Neeshe Bhikhubhai Williams is registered as director of Pharmanovia A/S.
As of September 30, 2025, James Sang Bum Lee has stepped down as director of Pharmanovia A/S.
As of August 25, 2025, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Pharmanovia A/S.
As of August 19, 2025, KPMG P/S has stepped down as auditor of Pharmanovia A/S.
About Pharmanovia A/S
Pharmanovia A/S is a Danish company of the type Aktieselskab based in København S, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Atnahs Pharma Nordics A/S and PHARMANOVIA A/S. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. The company has 3 employees (2026). In 2026, the company reported a gross profit of EUR 11,734,813 and a net result of EUR 7,730,657 compared with DKK 3,839,334 the year before. Equity in the 2026 report amounted to EUR 15,820,601.